The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Challenges and Opportunities in dermal/transdermal Delivery
Open accessAbstract
Transdermal drug delivery is an exciting and challenging area. There are numerous transdermal delivery systems currently available on the market. However, the transdermal market still remains limited to a narrow range of drugs. Further advances in transdermal delivery depend on the ability to overcome the challenges faced regarding the permeation and skin irritation of the drug molecules. Emergence of novel techniques for skin permeation enhancement and development of methods to lessen skin irritation would widen the transdermal market for hydrophilic compounds, macromolecules and conventional drugs for new therapeutic indications. As evident from the ongoing clinical trials of a wide variety of drugs for various clinical conditions, there is a great future for transdermal delivery of drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · Applied Ergonomics · doi:10.1016/0003-6870(92)90318-p · Cited by 5,737
Prausnitz, M. R., & Langer, R. (2008) · Nature Biotechnology · doi:10.1038/nbt.1504 · Cited by 3,517
Microneedles for transdermal drug delivery
Prausnitz, M. R. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.023 · Cited by 1,521
The 500 Dalton rule for the skin penetration of chemical compounds and drugs
Bos, J. D., & Meinardi, M. M. H. M. (2000) · Experimental Dermatology · doi:10.1034/j.1600-0625.2000.009003165.x · Cited by 1,465
Current status and future potential of transdermal drug delivery
Prausnitz, M. R., Mitragotri, S., & Langer, R. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1304 · Cited by 1,462
Microfabricated Microneedles: A Novel Approach to Transdermal Drug Delivery
Henry, S., McAllister, D. V., Allen, M. G., & Prausnitz, M. R. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980042+ · Cited by 1,346
The pH of the Skin Surface and Its Impact on the Barrier Function
Schmid-Wendtner, M.-H., & Korting, H. C. (2006) · Skin Pharmacology and Physiology · doi:10.1159/000094670 · Cited by 860
Drug permeation through human skin: Theory and invitro experimental measurement
Michaels, A. S., Chandrasekaran, S. K., & Shaw, J. E. (1975) · AIChE Journal · doi:10.1002/aic.690210522 · Cited by 801
Ultrasound-Mediated Transdermal Protein Delivery
Mitragotri, S., Blankschtein, D., & Langer, R. (1995) · Science · doi:10.1126/science.7638603 · Cited by 791
Coated microneedles for transdermal delivery
Gill, H. S., & Prausnitz, M. R. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.017 · Cited by 765
Cited by
Alkilani, A., McCrudden, M. T., & Donnelly, R. (2015) · Pharmaceutics · doi:10.3390/pharmaceutics7040438 · Cited by 1,147
Larrañeta, E., Lutton, R. E. M., Woolfson, A. D., & Donnelly, R. F. (2016) · Materials Science and Engineering: R: Reports · doi:10.1016/j.mser.2016.03.001 · Cited by 964
Ahmed, T., & Aljaeid, B. (2016) · Drug Design, Development and Therapy · doi:10.2147/dddt.s99651 · Cited by 705
Enhancement strategies for transdermal drug delivery systems: current trends and applications
Ramadon, D., McCrudden, M. T. C., Courtenay, A. J., & Donnelly, R. F. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00909-6 · Cited by 649
Rai, V. K., Mishra, N., Yadav, K. S., & Yadav, N. P. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.049 · Cited by 619
Approaches for breaking the barriers of drug permeation through transdermal drug delivery
Alexander, A., Dwivedi, S., Ajazuddin, Giri, T. K., Saraf, S., Saraf, S., & Tripathi, D. K. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.09.017 · Cited by 563
Yu, Y.-Q., Yang, X., Wu, X.-F., & Fan, Y.-B. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.646554 · Cited by 441
Sala, M., Diab, R., Elaissari, A., & Fessi, H. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.10.046 · Cited by 428
Polymeric nanoparticles‐based topical delivery systems for the treatment of dermatological diseases
Zhang, Z., Tsai, P., Ramezanli, T., & Michniak‐Kohn, B. B. (2013) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1211 · Cited by 357
Ghasemiyeh, P., & Mohammadi-Samani, S. (2020) · Drug Design, Development and Therapy · doi:10.2147/dddt.s264648 · Cited by 346
Drug delivery applications of chitin and chitosan: a review
Parhi, R. (2020) · Environmental Chemistry Letters · doi:10.1007/s10311-020-00963-5 · Cited by 307
Transdermal cannabidiol reduces inflammation and pain‐related behaviours in a rat model of arthritis
Hammell, D. C., Zhang, L. P., Ma, F., Abshire, S. M., McIlwrath, S. L., Stinchcomb, A. L., & Westlund, K. N. (2016) · European Journal of Pain · doi:10.1002/ejp.818 · Cited by 300
Self-citationDoktorovová, S., Kovačević, A. B., Garcia, M. L., & Souto, E. B. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.08.001 · Cited by 293
Jain, S., Patel, N., Shah, M. K., Khatri, P., & Vora, N. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.10.001 · Cited by 283
Microneedle-Based Delivery: An Overview of Current Applications and Trends
Guillot, A. J., Cordeiro, A. S., Donnelly, R. F., Montesinos, M. C., Garrigues, T. M., & Melero, A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12060569 · Cited by 254
Gupta, V., & Trivedi, P. (2018) · Lipid Nanocarriers for Drug Targeting · doi:10.1016/b978-0-12-813687-4.00015-3 · Cited by 96
Tariot, P. N., Braeckman, R., & Oh, C. (2022) · Journal of Alzheimer's Disease · doi:10.3233/jad-220530 · Cited by 24
Metadata
- Authors
- Paudel, K. S., Milewski, M., Swadley, C. L., Brogden, N. K., Ghosh, P., & Stinchcomb, A. L.
- Venue
- Therapeutic Delivery
- Publisher
- Informa UK Limited
- Published
- 2010-06-25
- Volume
- 1
- Issue
- 1
- Pages
- 109-131
- ISSN
- 2041-5990 (ISSN-L)
- 2041-6008
- OpenAlex
- W2016181184
- Cited by
- 616
- References
- 74
- FWCI
- 5.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.